Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | 13.9B | 13.5B | 14.7B | 13.8B |
Cost of revenue | 8.6B | 8.5B | 9.3B | 8.7B |
Gross profit | 5.3B | 5.0B | 5.3B | 5.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 2.7B | 2.4B | 2.9B | 2.7B |
Non operating interest income | ||||
Income | 8M | 20M | 13M | 4M |
Expense | 5M | 59M | 37M | 62M |
Other income expense | — | — | — | — |
Pretax income | 3.1B | 2.7B | 2.7B | 2.7B |
Tax provision | 673M | 871M | 820M | 863M |
Net income | 2.4B | 1.8B | 1.9B | 1.9B |
Basic EPS | — | — | — | 30.6 |
Diluted EPS | — | — | — | 27.3 |
Basic average shares | — | — | — | 60.7M |
Diluted average shares | — | — | — | 68.1M |
EBITDA | 3.0B | 2.8B | 2.8B | 2.8B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |